Identification Module
The Identification Module contains basic identifying information about the clinical trial, including the NCT ID, brief title, official title, acronym, organization study ID information, and organization details. This module provides essential identifiers for the trial.
Identification Module path is as follows:
Study -> Protocol Section -> Identification Module
Identification Module
Ignite Creation Date:
2025-12-24 @ 2:38 PM
Ignite Modification Date:
2025-12-24 @ 2:38 PM
NCT ID:
NCT00070759
Brief Title:
Daclizumab to Treat Non-Infectious Sight-Threatening Uveitis
Official Title:
Daclizumab for Active, Non-infectious, Sight-threatening Uveitis: A Phase II Pilot Study
Study:
NCT00070759
Protocol Section:
NCT00070759